Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

79.49 +3.24 (+4.25%)

Streaming Delayed Price Updated: 3:29 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

10 Biggest Price Target Changes For Thursday ↗

August 19, 2021

Needham boosted the price target on NVIDIA Corporation (NASDAQ:

Via Benzinga

46 Biggest Movers From Yesterday ↗

August 19, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67...

Via Benzinga

Alcon inc (ALC) Q2 2021 Earnings Call Transcript ↗

August 18, 2021

ALC earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet ↗

August 18, 2021

Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropping 0.21% to 4,438.73. The U.S....

Via Benzinga

Topics Stocks

Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide ↗

August 18, 2021

Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to 4,443.63. The U.S. has...

Via Benzinga

Topics Stocks

34 Stocks Moving In Wednesday's Mid-Day Session ↗

August 18, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $...

Via Benzinga

22 Stocks Moving in Wednesday's Pre-Market Session ↗

August 18, 2021

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 50.6% to $23.12 in pre-market trading. Virpax Pharmaceuticals shares jumped 265% on Tuesday after the company...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Fed Minutes ↗

August 18, 2021

Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade ahead of the release of minutes from the Fed meeting. Investors are awaiting earnings results from...

Via Benzinga

Topics Economy

Investors Cheer Alcon's Updated Annual Guidance ↗

August 18, 2021

Alcon AG (NYSE: ALC) reported second-quarter FY21 sales of $2.1 billion, +75% Y/Y on a reported basis and +69% on a constant currency basis, beating the consensus of $1...

Via Benzinga

Alcon Reports Second Quarter 2021 Results

August 17, 2021

From Alcon Inc. Investors

Via Business Wire

Earnings Scheduled For August 17, 2021 ↗

August 17, 2021

Companies Reporting Before The Bell • AiHuiShou Intl (NYSE:RERE) is expected to report earnings for its second quarter. • Ozon Holdings (NASDAQ:OZON) is expected...

Via Benzinga

Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens

August 11, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021

July 22, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon Announces Executive Committee Changes

June 28, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021

June 07, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon Inc (ALC) Q1 2021 Earnings Call Transcript ↗

May 05, 2021

ALC earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Alcon's Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations ↗

May 05, 2021

Alcon AG (NYSE: ALC) reported first-quarter FY21 sales of $1.9 billion, an increase of 5% Y/Y on a reported basis and 2% on a constant currency basis,...

Via Benzinga

Alcon Reports First Quarter 2021 Results

May 04, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza

April 28, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting

April 28, 2021

From Alcon Inc. Investors

Via Business Wire

Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.

April 28, 2021

From Alcon Inc. Investors

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.